New Jersey · 2026-2027 Regular Session · Bill
A 692: Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 692 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans. Primary sponsor: Greg McGuckin (Republican), Paul Kanitra (Republican). Most recent recorded action (January 13, 2026): Introduced, Referred to Assembly Education Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Greg McGuckin | Primary sponsor | Republican | House | 10 |
| Paul Kanitra | Primary sponsor | Republican | House | 10 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Introduced, Referred to Assembly Education Committee